A word from the Director

Stephen Walters

Welcome to the first of a series of newsletters from the Design, Trials and Statistics (DTS) section at the University of Sheffield. We are aiming to communicate with many people - colleagues and collaborators, clients and research funding bodies, potential and previous students. Everyone we know will be added to our mailing list, and if you’ve received the newsletter second-hand please e-mail your contact details to claire.white@sheffield.ac.uk to join the list.

Design, Trials & Statistics (DTS) is a section within the School of Health and Related Research (ScHARR) and consists of three subgroups:

  1. National Institute for Health Research (NIHR) Research Design Service for Yorkshire and the Humber (RDS YH);
  2. Clinical Trials Research Unit (CTRU);
  3. Medical Statistics Group (MSG).

The group aims to design, conduct, analyse and report high quality randomised controlled trials (RCTs) and other studies to evaluate the effectiveness of new services, therapies and health technologies; with the aim of improving the health of the public at local, regional, national and international levels.
The group also aims to develop and deliver excellent quality, research-informed teaching relevant to today's students, at undergraduate, postgraduate and professional development levels.

The DTS section brings together a range of disciplines with the ultimate goal of carrying out high quality research to benefit patient care, through the improved methodology of clinical trials. The better the design, conduct, analysis and reporting of a trial, the more likely it will be to give unbiased, precise and relevant results that will maximise the chance of making the correct conclusions regarding its use in routine clinical practice. If the correct decision is made then patients will benefit. Such research will have a major impact on clinicians, providing them with improved evidence on which to base their medical decisions and to policy decision makers providing robust results to inform health policy (e.g. NICE appraisals). This improved decision-making will benefit patients.

We can assist your research from the earliest stages from identifying funding sources and protocol development through to implementation and publication. If you have a study in mind, please contact us to discuss your requirements.

I hope you enjoy the newsletter.  Please do get in touch if you wish to work with us on these issues.

Professor Stephen Walters